We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
AUM
$160M
AUM Growth
+$15.9M
Cap. Flow
+$6.81M
Cap. Flow %
4.26%
Top 10 Hldgs %
31.05%
Holding
148
New
17
Increased
36
Reduced
37
Closed
18

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$2.78M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$1.4M
3
WU icon
Western Union
WU
+$1.03M
4
DD
Du Pont De Nemours E I
DD
+$845K
5
TEX icon
Terex
TEX
+$811K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.04%
2 Real Estate 13.42%
3 Energy 12.85%
4 Technology 11.92%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GM
1
DELISTED
GEN MOTORS CORP
GM
$6.61M 4.14%
182,168
+10,733
+6% +$390K
BKTI icon
2
BK Technologies
BKTI
$283M
$5.91M 3.69%
306,051
+8,800
+3% +$153K
YHOO
3
DELISTED
Yahoo Inc
YHOO
$5.69M 3.56%
161,900
+95,900
+145% +$3.35M
DVN icon
4
Devon Energy
DVN
$51.8B
$5.47M 3.42%
68,903
+6,867
+11% +$500K
CORE
5
DELISTED
Core Mark Holding Co., Inc.
CORE
$5.01M 3.13%
219,600
-4,400
-2% -$90K
GE icon
6
GE Aerospace
GE
$356B
$4.74M 2.96%
37,619
-653
-2% -$83K
AAPL icon
7
Apple
AAPL
$4.59T
$4.47M 2.8%
192,392
+21,312
+12% +$454K
HTGC icon
8
Hercules Capital
HTGC
$3.28B
$4.06M 2.54%
251,236
+19
+0% +$278
CVA
9
DELISTED
Covanta Holding Corporation
CVA
$4.05M 2.53%
196,325
+12,500
+7% +$236K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$3.64M 2.27%
34,762
+61
+0.2% +$6.17K
PFE icon
11
Pfizer
PFE
$160B
$3.34M 2.09%
118,575
+316
+0.3% +$9.01K
SIR
12
DELISTED
SELECT INCOME REIT
SIR
$3.12M 1.95%
+239,671
New +$3.13M
MSFT icon
13
Microsoft
MSFT
$3.75T
$2.94M 1.84%
70,526
-1,725
-2% -$69.8K
MDLZ icon
14
Mondelez International
MDLZ
$79.7B
$2.84M 1.78%
75,533
-833
-1% -$30.4K
WFC icon
15
Wells Fargo
WFC
$257B
$2.75M 1.72%
52,344
-4,181
-7% -$210K
CLNE icon
16
Clean Energy Fuels
CLNE
$353M
$2.68M 1.68%
229,000
+25,100
+12% +$249K
SPA
17
DELISTED
Sparton
SPA
$2.6M 1.62%
93,568
-3,500
-4% -$98.1K
BMY icon
18
Bristol-Myers Squibb
BMY
$137B
$2.51M 1.57%
51,800
-300
-0.6% -$14.8K
CLNY
19
DELISTED
Colony Capital, Inc.
CLNY
$2.33M 1.46%
100,267
-967
-1% -$21.2K
MFA
20
MFA Financial
MFA
$896M
$2.08M 1.3%
63,479
+11,627
+22% +$376K
ABR icon
21
Arbor Realty Trust
ABR
$938M
$2.04M 1.28%
293,383
+58,467
+25% +$413K
CNOB icon
22
Center Bancorp
CNOB
$1.61B
$1.96M 1.22%
101,804
-500
-0.5% -$9.33K
DEM icon
23
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
$1.9M 1.19%
36,600
FCX icon
24
Freeport-McMoran
FCX
$113B
$1.88M 1.17%
51,400
-9,800
-16% -$335K
HHH icon
25
Howard Hughes
HHH
$3.88B
$1.85M 1.16%
12,326
-2,622
-18% -$366K

Similar funds

Benchmark Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Benchmark Capital Advisors held 148 positions worth $160M, up 11% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors deployed $6.81M of net new capital in Q2 2014, opening 17 new positions and adding to 36 existing holdings. Its largest new stake was SELECT INCOME REIT: 239,671 shares worth $3.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 18% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Qualcomm, an estimated $2.78M trimmed.

  • Benchmark Capital Advisors's largest Q2 2014 buy was SELECT INCOME REIT: 239,671 shares worth $3.12M.
  • Benchmark Capital Advisors added most to Yahoo Inc in Q2 2014, an estimated $3.35M increase.
  • Benchmark Capital Advisors's biggest Q2 2014 reduction was Qualcomm, cutting an estimated $2.78M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q2 2014, selling an estimated $1.4M.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $160M portfolio in Q2 2014.
  • Benchmark Capital Advisors opened 17 new positions and closed 18 in Q2 2014.
  • Benchmark Capital Advisors's portfolio value rose 11% quarter-over-quarter to $160M.

Based on Benchmark Capital Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.